Titles and Authors of Articles and Commentaries.

Publikováno v: Quarterly Review of Biology. 2022, Vol. 97 Issue 4, p321-323. 3p.

Carlo Cattaneo. I temi e le sfide. Convegno internazionale di studi, Milano-Lugano, 6-8 novembre 2001. Nota al convegno

Autor: Maggi, Stefano

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1820::0e6f4e9f3544878d967768c37aad7a92
http://hdl.handle.net/11365/33952

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1.

Autor: Cattaneo I; Division of Hematology, Center of Cellular Therapy 'G. Lanzani', Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, 24122 Bergamo, Italy., Choblet S; Centre National de la Recherche Scientifique UAR3426 'Baculovirus et Therapie', 30380 Saint-Christol-Lez-Alès, France., Valgardsdottir R; Division of Hematology, Center of Cellular Therapy 'G. Lanzani', Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, 24122 Bergamo, Italy., Roth M; Centre National de la Recherche Scientifique UAR3426 'Baculovirus et Therapie', 30380 Saint-Christol-Lez-Alès, France., Massafra A; Laboratory of Pharmacodynamics and Pharmacokinetics, Department of Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS, 20157 Milan, Italy., Beeg M; Laboratory of Pharmacodynamics and Pharmacokinetics, Department of Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS, 20157 Milan, Italy., Gobbi M; Laboratory of Pharmacodynamics and Pharmacokinetics, Department of Biochemistry and Pharmacology, Istituto di Ricerche Farmacologiche Mario Negri-IRCCS, 20157 Milan, Italy., Duonor-Cerutti M; Centre National de la Recherche Scientifique UAR3426 'Baculovirus et Therapie', 30380 Saint-Christol-Lez-Alès, France., Golay J; Division of Hematology, Center of Cellular Therapy 'G. Lanzani', Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, 24122 Bergamo, Italy.

Publikováno v: Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2024 Feb 20; Vol. 13 (1). Date of Electronic Publication: 2024 Feb 20.

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis.

Autor: Horgan D; European Alliance for Personalised Medicine, 1040 Brussels, Belgium.; Department of Molecular and Cellular Engineering, Jacob Institute of Biotechnology and Bioengineering, Faculty of Engineering and Technology, Sam Higginbottom University of Agriculture, Technology and Sciences, Prayagraj 211007, India., Bulcke MVD; Belgian Cancer Centre, Sciensano, 1050 Brussels, Belgium., Malapelle U; Department of Public Health, University Federico II of Naples, 80138 Naples, Italy., Normanno N; Istituto Nazionale Tumori 'Fondazione G. Pascale'-IRCCS, 80131 Naples, Italy., Capoluongo ED; Dipartimento di Eccellenza in Medicina Molecolare e Biotecnologie Mediche, Università Federico II, 80138 Naples, Italy.; Department of Clinical Pathology and Genomics, Azienda Ospedaliera Per L'Emergenza Cannizzaro, 95126 Catania, Italy., Prelaj A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy., Rizzari C; Unità di Ematologia Pediatrica, Fondazione MBBM, Università di Milano-Bicocca, 20126 Monza, Italy., Stathopoulou A; European Cancer Patient Coalition, 1000 Brussels, Belgium., Singh J; European Alliance for Personalised Medicine, 1040 Brussels, Belgium., Kozaric M; European Alliance for Personalised Medicine, 1040 Brussels, Belgium., Dube F; Astra Zeneca, Concord Pike, Wilmington, DE 19803, USA., Ottaviano M; Departamento de Tecnología Fotónica y Bioingeniería, Universidad Politècnica de Madrid, 28040 Madrid, Spain., Boccia S; Section of Hygiene, Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, 20123 Rome, Italy.; Departments of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy., Pravettoni G; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.; Applied Research Division for Cognitive and Psychological Science, European Institute of Oncology (IEO) IRCCS, 20139 Milan, Italy., Cattaneo I; Novartis Farma SpA, 20154 Milano, Italy., Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), 28029 Madrid, Spain., Buettner R; Lung Cancer Group Cologne, Institute of Pathology and Medical Faculty, Center for Integrated Oncology Cologne/Bonn, University Hospital Cologne, 50937 Cologne, Germany., Lekadir K; Artificial Intelligence in Medicine Lab (BCN-AIM), Universitat de Barcelona, 08007 Barcelona, Spain., de Lorenzo F; European Cancer Patient Coalition, 1000 Brussels, Belgium., Blanc P; Imagine for Margo, 78100 Saint-Germain-en-Laye, France., Alix-Panabieres C; Laboratory of Rare Human Circulating Cells, University Medical Center of Montpellier, 34093 Montpellier, France., Badreh S; Cancer Childhood International, 1200 Vienna, Austria., Hofman P; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Université Côte d'Azur, 06000 Nice, France., Solary E; INSERM U1287, Gustave Roussy Cancer Campus, 94805 Villejuif, France.; Faculty of Medicine, Université Paris-Sud, Le Kremlin-Bicêtre, 91405 Île-de-France, France.; Department of Hematology, Gustave Roussy Cancer Campus, 94805 Paris, France., De Maria R; Institute of General Pathology, Catholic University of the Sacred Heart, 20123 Rome, Italy.

Publikováno v: Healthcare (Basel, Switzerland) [Healthcare (Basel)] 2024 Jan 19; Vol. 12 (2). Date of Electronic Publication: 2024 Jan 19.